Patent · US Active

Compositions and methods for treating respiratory syncytial virus infection

US9556236B1 · kind B1 · utility

1Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2013
Grant dateJan 31, 2017
Priority date
Expiry dateMar 23, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/18033
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Briefly described, embodiments of the present disclosure relate to isolated polypeptides useful for treatment of respiratory syncytial virus, and to methods and compositions for treating respiratory syncytial virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.